Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M653Revenue (TTM) $M570Net Margin (%)-12.3Altman Z-Score--
Enterprise Value $M653EPS (TTM) $-1.8Operating Margin %-3.3Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)-10.5Higher ROA y-yN
Price/Book1.910-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales1.05-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %-137.8ROA % (ttm)-7.7Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-24.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M42.9ROIC % (ttm)-0.1Gross Margin Increase y-yN

Gurus Latest Trades with AMRI

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

AMRI is held by these investors:



AMRI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MADDALUNA ANTHONY JDirector 2016-12-02Buy1,518$16.46-7.53view
Hagen Steven RSVP Manufacturing & Pharmaceut 2016-11-30Sell9,000$16.71-8.92view
HENDERSON LORI M.SVP, Secretary & Gen Counsel 2016-11-16Sell6,000$17-10.47view
Hagen Steven RSVP Manufacturing & Pharmaceut 2016-11-10Sell785$16.79-9.35view
Hagen Steven RSVP Manufacturing & Pharmaceut 2016-08-09Sell1,401$15.29-0.46view
OCONNOR KEVINDirector 2016-05-31Sell5,000$14.415.62view
Marth William SPresident and CEO 2016-05-16Buy12,500$12.8618.35view
Svokos GeorgeCOO 2016-05-13Buy12,500$12.8218.72view
Hagen Steven RSVP Manufacturing & Pharmaceut 2016-05-13Sell2,361$12.7719.19view
D AMBRA THOMAS EChairman, Board of Directors 2015-11-09Sell50,000$19.6-22.35view

Press Releases about AMRI :

Quarterly/Annual Reports about AMRI:

News about AMRI:

Articles On GuruFocus.com
Weekly CFO Buys Highlight: TSON, PRTS, FXCM, AMRI, MN Dec 05 2011 

More From Other Websites
Albany Molecular Research, Inc. :AMRI-US: Earnings Analysis: Q4, 2016 By the Numbers : February 22,... Feb 22 2017
Albany Molecular Research 4Q Net Misses Street Feb 22 2017
Albany Molecular Research, Inc. breached its 50 day moving average in a Bearish Manner : AMRI-US :... Feb 22 2017
ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K, Results of Operations and Financial Condition,... Feb 21 2017
Edited Transcript of AMRI earnings conference call or presentation 21-Feb-17 1:30pm GMT Feb 21 2017
Albany Molecular Research posts 4Q loss Feb 21 2017
Albany Molecular Research posts 4Q loss Feb 21 2017
AMRI Announces Agreement with Accord Healthcare to Jointly Develop, Manufacture and Commercialize... Feb 21 2017
AMRI Announces Fourth Quarter and Full Year 2016 Results and Provides 2017 Outlook Feb 21 2017
Q4 2016 Albany Molecular Research Inc Earnings Release - Before Market Open Feb 21 2017
[2/15] Today's Top 10 Long/Short Estimize Signal Scores Feb 15 2017
AMRI Schedules Fourth Quarter and Full Year 2016 Earnings Release and Conference Call Feb 15 2017
[2/7] Today's Top 10 Long/Short Estimize Signal Scores Feb 07 2017
AMRI Announces Strategic Alliance to Advance Mass Spectrometry Capabilities for Drug Discovery Feb 07 2017
Albany Molecular Research, Inc. – Value Analysis (NASDAQ:AMRI) : January 20, 2017 Jan 20 2017
Albany Molecular Research, Inc. breached its 50 day moving average in a Bullish Manner : AMRI-US :... Jan 19 2017
ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K, Other Events Dec 22 2016
AMRI CEO to Present at 35th Annual J.P. Morgan Healthcare Conference Dec 13 2016
Is Instructure Inc (INST) A Good Stock to Buy? Dec 12 2016
Is Albany Molecular Research, Inc. (AMRI) A Good Stock To Buy? Dec 05 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)